InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: drv17 post# 160380

Sunday, 07/29/2018 10:33:32 AM

Sunday, July 29, 2018 10:33:32 AM

Post# of 465280

What is/was the consensus of the 9,000,000 shares traded on 7/3?
I don't recall that there was a lot of discussion about this




A major development occurred on 7/3 imho.

“NEW YORK – July 3, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that the Company has received approval by the Australian Human Research Ethics Committee to initiate its Phase 2b/3 double-blind, randomized, placebo-controlled, 48-week safety and efficacy trial of ANAVEX®2-73 for the treatment of early Alzheimer’s disease. “

https://www.anavex.com/anavex-life-sciences-receives-approval-to-initiate-phase-2b-3-clinical-trial-of-anavex2-73-for-the-treatment-of-early-alzheimers-disease/


Too bad the Cantor agreement wasn’t in effect at the time. Probably a missed opportunity imho.



“On July 6, 2018,
Anavex Life Sciences Corp. (the “Company”) entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co., as agent (“Cantor Fitzgerald”), pursuant to which the Company may offer and sell shares of common stock, par value $0.001 per share (the “Shares”), for aggregate gross sale proceeds of up to $50,000,000 from time to time through Cantor Fitzgerald (the “Offering”).

http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12851999&RcvdDate=7/6/2018&CoName=ANAVEX%20LIFE%20SCIENCES%20CORP.&FormType=8-K&View=html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News